Back to BlackRock, Inc. BlackRock, Inc.

AVIRAVIR
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ATEA PHARMACEUTICALS INC

BlackRock, Inc. holds 8.7M shares of AVIR (ATEA PHARMACEUTICALS INC), worth $40.5M as of 2026-Q2. The position was increased (+3.4% shares). AVIR represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$40.5M

Current Shares

8.7M

Total Value Change

+$10.2M

Total Shares Change

-342,104

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.7M
+3.4%
$40.5M0.0%$4.65
30
2026-Q1
Decreased
8.4M
-0.7%
$45.4M0.0%$4.82
0
2025-Q4
Increased
8.5M
+0.4%
$30.3M0.0%$3.55
29
2025-Q3
Decreased
8.5M
-2.4%
$24.5M0.0%$2.92
0
2025-Q2
Decreased
8.7M
-3.1%
$31.2M0.0%$3.45
0
2025-Q1
Decreased
8.9M
-1.3%
$26.7M0.0%$2.93
0
2024-Q4
New
9.1M
-
$30.4M0.0%$3.33
40

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used